Literature DB >> 3308956

Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

L Rossetti1, G I Shulman, W Zawalich, R A DeFronzo.   

Abstract

We have examined the effect of chronic (4 wk) hyperglycemia on insulin secretion in vivo in an awake, unstressed rat model. Three groups of animals were examined: control, partial (90%) pancreatectomy, and partial pancreatectomy plus phlorizin, in order to normalize plasma glucose levels. Insulin secretion in response to arginine (2 mM), hyperglycemia (+100 mg/dl), and arginine plus hyperglycemia was evaluated. In diabetic compared with control animals three specific alterations were observed: (a) a deficient insulin response, in both first and second phases, to hyperglycemia; (b) an augmented insulin response to the potentiating effect of arginine under basal glycemic conditions; and (c) an inability of hyperglycemia to augment the potentiating effect of arginine above that observed under basal glycemic conditions. Normalization of the plasma glucose profile by phlorizin treatment in diabetic rats completely corrected all three beta cell abnormalities. These results indicate that chronic hyperglycemia can lead to a defect in in vivo insulin secretion which is reversible when normoglycemia is restored.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308956      PMCID: PMC442343          DOI: 10.1172/JCI113157

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Inhibition of insulin secretion by exogenous insulin in normal man as demonstrated by C-peptide assay.

Authors:  J E Liljenquist; D L Horwitz; A S Jennings; J L Chiasson; U Keller; A H Rubenstein
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

Review 2.  Mechanism of glucose-induced insulin secretion.

Authors:  C J Hedeskov
Journal:  Physiol Rev       Date:  1980-04       Impact factor: 37.312

3.  Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration.

Authors:  R A DeFronzo; R Hendler; N Christensen
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

4.  Islet secretion in a new experimental model for non-insulin-dependent diabetes.

Authors:  G C Weir; E T Clore; C J Zmachinski; S Bonner-Weir
Journal:  Diabetes       Date:  1981-07       Impact factor: 9.461

5.  Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

Authors:  K Kosaka; T Kuzuya; Y Akanuma; R Hagura
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

6.  The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus.

Authors:  P Westermark; E Wilander
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

7.  The pancreatic islets in diabetes.

Authors:  W Gepts; P M Lecompte
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

8.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  Insulin secretion in diabetes mellitus.

Authors:  M A Pfeifer; J B Halter; D Porte
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

View more
  82 in total

Review 1.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

2.  To: Godsland IF, Jeffs JA, Johnston DG (2004) loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166.

Authors:  M A Abdul-Ghani; R A DeFronzo
Journal:  Diabetologia       Date:  2005-08-17       Impact factor: 10.122

Review 3.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 4.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

5.  Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.

Authors:  R P Robertson; H J Zhang; K L Pyzdrowski; T F Walseth
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 6.  Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor.

Authors:  Damayanthi Devineni; David Polidori
Journal:  Clin Pharmacokinet       Date:  2015-10       Impact factor: 6.447

7.  Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Authors:  V Delghingaro-Augusto; C J Nolan; D Gupta; T L Jetton; M G Latour; M Peshavaria; S R Murthy Madiraju; E Joly; M-L Peyot; M Prentki; J Leahy
Journal:  Diabetologia       Date:  2009-03-18       Impact factor: 10.122

8.  In vivo insulin resistance in streptozotocin-diabetic rats--evidence for reversal following oral vanadate treatment.

Authors:  O Blondel; D Bailbe; B Portha
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

9.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

Authors:  A Gastaldelli; E Ferrannini; Y Miyazaki; M Matsuda; R A DeFronzo
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

10.  Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.

Authors:  P M Clark; J C Levy; L Cox; M Burnett; R C Turner; C N Hales
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.